Challenge: can you describe the aim of this project in 10 words? Our aim is to understand how AML can become resistant to chemotherapy and return with a vengeance. Why are you focusing on core-binding factor AML? In general, outcomes in AMLs are poor. The dogma is that core-binding factor AMLs respond well to initial ...
Dr Edward Chew: identifying the genes responsible for poor AML outcomes
23 Mar 2018